The Ophthalmologist / Companies / EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

DEXYCU: Jason Bacharach

December 9, 2019

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

1 min read

DEXYCU: Jason Bacharach

DEXYCU: Mark Pyfer

December 6, 2019

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

1 min read

DEXYCU: Mark Pyfer

DEXYCU: Michael Savetsky

November 21, 2019

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

1 min read

DEXYCU: Michael Savetsky

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Browse by Subspecialties

Cataract Cornea Glaucoma Neuro-ophthalmology Oculoplastics Optometry Pediatric Retina

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: